Conference
Trajectory of Symptoms after Autologous Stem Cell Transplant Among Patients with Multiple Myeloma: A Population-Based Study
Abstract
Introduction
Autologous stem cell transplant (ASCT) remains the standard of care for eligible patients with multiple myeloma (MM). There is a paucity of data with regards to the symptom burden experienced by patients undergoing ASCT. In 2007, routine prospective collection of patient-reported outcome (PROs), Edmonton Symptoms Assessment System (ESAS), was initiated in all outpatient cancer clinics in Ontario, Canada. The ESAS …
Authors
Mian HS; Pond GR; Wildes TM; Sivapathasundaram B; Sussman J; Seow H
Volume
136
Pagination
pp. 1-2
Publisher
American Society of Hematology
Publication Date
November 5, 2020
DOI
10.1182/blood-2020-133869
Conference proceedings
Blood
Issue
Supplement 1
ISSN
0006-4971